Bleichroeder
Bleichroeder reported 78 stocks worth $559M in its 13F filing for Q2 2026, filed Aug 13, 2026. Its largest holdings are GLD (31.3%), GPGI (11.3%) and SPY (9.0%). Compared with Q1 2026, the fund opened new positions in CUE, COGT and SPIR, added to DTIL, LIQT and CGEM, trimmed LIN, IDN and FLNT and sold out of CUE, POCI and RTX.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  GLD Spdr Gold TR | $175M | 31.3% | 475K | No change | 8 of 8 | |
| 2 |  GPGI Composecure Inc | $63M | 11.3% | 4M | No change | 8 of 8 | |
| 3 |  SPY Spdr S&P 500 ETF TR | $50.5M | 9.0% | 68K | No change | 8 of 8 | |
| 4 |  RHLD Resolute Hldgs Mgmt Inc | $45.4M | 8.1% | 314K | No change | 6 of 8 | |
| 5 |  LIN Linde PLC | $31.4M | 5.6% | 60K | −8,040 (−12%) | 8 of 8 | |
| 6 |  DUOT Duos Technologies Group Inc | $19.5M | 3.5% | 1.6M | No change | 8 of 8 | |
| 7 |  DTIL Precision Biosciences Inc | $15.9M | 2.8% | 2M | +356K (+21%) | 6 of 8 | |
| 8 |  CUE Cue Biopharma Inc Com | $11.7M | 2.1% | 371K | New position | 1 of 8 | |
| 9 |  BX Blackstone Inc | $10.7M | 1.9% | 91K | No change | 8 of 8 | |
| 10 |  IMMX Immix Biopharma Inc | $10.3M | 1.8% | 1M | No change | 8 of 8 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
NEUROONE MED TECHNOLOGIES CO | $3.1M | 4M |
CUE Cue Biopharma Inc | $1.6M | 6.8M |
 POCI Precision Optics Corp Inc MA | $1.2M | 271K |
 RTX Rtx Corp | $1.2M | 6,000 |
 SHAZ Sharonai Holdings Inc | $568K | 25K |
🔒 Free account: see all 12.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 13, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Bleichroeder 13F FAQ
What does Bleichroeder own?
Bleichroeder reported 78 stocks worth $559M in its 13F filing for Q2 2026, filed Aug 13, 2026. Its largest holdings are GLD (31.3%), GPGI (11.3%) and SPY (9.0%). The table above lists every position in the filing (the top 10 without an account).
What did Bleichroeder buy and sell in Q2 2026?
Compared with Q1 2026: 9 new positions, 7 added to, 7 trimmed and 12 sold out. New positions include CUE, COGT and SPIR. It sold all of CUE, POCI and RTX.
When will Bleichroeder file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Bleichroeder's portfolio worth?
The Q2 2026 filing reports $559M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.